0.80%| Prev Close: | 3.02 |
|---|---|
| Open: | 3.06 |
| Bid: | N/A |
| Ask: | 3.12 x 300 |
| 1y Target Est: | 6.83 |
| Beta: | 2.71 |
| Next Earnings Date: | N/A |
| Day's Range: | 3.00 - 3.12 |
|---|---|
| 52wk Range: | 1.62 - 5.14 |
| Volume: | 238,617 |
| Avg Vol (3m): | 252,644 |
| Market Cap: | 181.09M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.32 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Neptune Responds to Aker's Continued Attempts to Deflect Attention From Its Sustained Patent InfringementGlobeNewswire(Wed, May 15)
- Class Action Lawsuit Against Neptune DismissedGlobeNewswire(Wed, May 15)
- Neptune to Hold Conference Call to Discuss Fourth Quarter and Fiscal 2013 ResultsGlobeNewswire(Thu, May 9)
- 5 Stocks Under $10 Set to Surgeat TheStreet(Thu, May 2)
- The U.S. International Trade Commission (ITC) Votes to Institute Patent Infringements Investigation Based on Neptune & Acasti ComplaintGlobeNewswire(Mon, Apr 15)
- Neptune Provides Update on European Patent Dispute and Maintains Its International Patent StrategyGlobeNewswire(Wed, Apr 10)
- Krill Oil's Omega-3s And CaPre: Brought To You By Acastiat Seeking Alpha(Wed, Apr 3)
- Neptune to Present at the Annual ROTH ConferenceGlobeNewswire(Thu, Mar 14)
- Neptune Obtains a Third U.S. Patent on Phospholipid Compositions, Further Bolstering Neptune's Request for an ITC InvestigationGlobeNewswire(Tue, Feb 26)
- On the Fly: Analyst Initiation Summarytheflyonthewall.com(Fri, Feb 15)
- Reasons to Buy This Pharmaceutical Companyat Motley Fool(Mon, Feb 11)
- Reducing 'Bad' LDL Cholesterol by Silencing Disease Causing GenesMarketwired(Mon, Feb 4)
- 5 Names Seeing Bullish Flowat TheStreet(Thu, Jan 31)
- Speculative Quasi-Biotech Neptune Off To A Strong Start In 2013at Seeking Alpha(Tue, Jan 29)
- Glancy Binkow & Goldberg LLP Announces Lead Plaintiff Deadline in the Class Action Lawsuit Against Neptune Technologies & Bioressources Inc.Business Wire(Sat, Jan 26)
Press Releases
- Neptune Responds to Aker's Continued Attempts to Deflect Attention From Its Sustained Patent InfringementGlobeNewswire(Wed, May 15)
- Class Action Lawsuit Against Neptune DismissedGlobeNewswire(Wed, May 15)
- Neptune to Hold Conference Call to Discuss Fourth Quarter and Fiscal 2013 ResultsGlobeNewswire(Thu, May 9)
Reports
- NEPTUNE TECHNOLOGIES INC (NEPT) 12-months forecastPechala's Reports(May 18)
- ValuEngine Industry Report for Medical-drugsValuEngine, Inc.(May 17)
- Neptune Tech & BioressourcesS&P Capital IQ Quantitative Report(May 11)